Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1Kanae Moriya, Hisanori Shimizu, Satoko Handa, et al.
Japanese Journal of Clinical Oncology|November 27, 2010
Psychiatric disorders in patients who lost family members to cancer and asked for medical help: descriptive analysis of outpatient services for bereaved families at Japanese cancer center hospitalMayumi Ishida, Hideki Onishi, Mei Wada, et al.
Investigational New Drugs|September 23, 2014
Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancerHirofumi Mukai, Toshiaki Saeki, Ken Shimada, et al.
Japanese Journal of Clinical Oncology|May 8, 2012
Psychological distress of the bereaved seeking medical counseling at a cancer centerMayumi Ishida, Hideki Onishi, Mei Matsubara, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2005
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR)Hiromichi Ebi, Yasushi Sigeoka, Toshiaki Saeki, et al.
Cancer Science|October 14, 2018
Lack of correlation between the costs of anticancer drugs and clinical benefits in JapanEtsuko Satoh, Yasutsuna Sasaki, Ryotaro Ohkuma, et al.
International Journal of Clinical Oncology|September 24, 2018
Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancerAyako Tsuboya, Ken-Ichi Fujita, Yutaro Kubota, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorinWataru Ichikawa, Akio Ooyama, Etsuko Toda, et al.
Japanese Journal of Clinical Oncology|September 10, 2016
Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib studyNorikazu Masuda, Hiroji Iwata, Kenjiro Aogi, et al.
Non-Coding RNA Research|July 29, 2021
Characteristics of miRNA-SNPs in healthy Japanese subjects and non-small cell lung cancer, colorectal cancer, and soft tissue sarcoma patientsKoki Katayama, Shimon Nakashima, Hiroo Ishida, et al.
Pageof 11